299 related articles for article (PubMed ID: 27433827)
1. Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.
Totonchy MB; McNiff JM; Bunick CG
J Cutan Pathol; 2016 Nov; 43(11):1031-1035. PubMed ID: 27433827
[TBL] [Abstract][Full Text] [Related]
2. Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease.
Casillas AC; Barragan VA; Alhalaseh Y; Modi MB; Lake E; Speiser JJ
J Cutan Pathol; 2023 Oct; 50(10):864-868. PubMed ID: 37430411
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized erythematous pustulosis occurring with Hailey-Hailey disease.
Deng A; Lowitt M
Skinmed; 2012; 10(4):251-3. PubMed ID: 23008946
[TBL] [Abstract][Full Text] [Related]
4. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
Huang YC; Shih PY; Chin SY; Chiang YY
J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
[No Abstract] [Full Text] [Related]
6. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
7. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
[No Abstract] [Full Text] [Related]
8. [Drug reaction with eosinophilia and systemic symptoms].
Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
[TBL] [Abstract][Full Text] [Related]
9. Treatments for Severe Cutaneous Adverse Reactions.
Cho YT; Chu CY
J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
[TBL] [Abstract][Full Text] [Related]
10. Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug.
Ozturk U; Sungur MA; Karakas T; Mulayim K; Ozturk P
Cutan Ocul Toxicol; 2015; 34(4):344-6. PubMed ID: 25363067
[TBL] [Abstract][Full Text] [Related]
11. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
12. Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use.
Levy ZD; Slowey M; Schulder M
Am J Emerg Med; 2017 Jul; 35(7):1036.e1-1036.e2. PubMed ID: 28189379
[TBL] [Abstract][Full Text] [Related]
13. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
Alniemi DT; Wetter DA; Bridges AG; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT
Int J Dermatol; 2017 Apr; 56(4):405-414. PubMed ID: 28084022
[TBL] [Abstract][Full Text] [Related]
14. Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis.
Tajmir-Riahi A; Wörl P; Harrer T; Schliep S; Schuler G; Simon M
Int Arch Allergy Immunol; 2017; 174(2):108-111. PubMed ID: 29065395
[TBL] [Abstract][Full Text] [Related]
15. Acute generalized exanthematous pustulosis (AGEP): A review and update.
Szatkowski J; Schwartz RA
J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
[TBL] [Abstract][Full Text] [Related]
16. DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series.
Soria A; Amsler E; Bernier C; Milpied B; Tétart F; Morice C; Dezoteux F; Ferrier-Le Bouedec MC; Barbaud A; Staumont-Sallé D; Assier H;
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3041-3050. PubMed ID: 33757916
[TBL] [Abstract][Full Text] [Related]
17. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
Pearson KC; Morrell DS; Runge SR; Jolly P
Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
[TBL] [Abstract][Full Text] [Related]
18. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
